[go: up one dir, main page]

AU2001234125A1 - Antibody library - Google Patents

Antibody library

Info

Publication number
AU2001234125A1
AU2001234125A1 AU2001234125A AU3412501A AU2001234125A1 AU 2001234125 A1 AU2001234125 A1 AU 2001234125A1 AU 2001234125 A AU2001234125 A AU 2001234125A AU 3412501 A AU3412501 A AU 3412501A AU 2001234125 A1 AU2001234125 A1 AU 2001234125A1
Authority
AU
Australia
Prior art keywords
antibody library
library
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001234125A
Inventor
Yasushi Akahori
Yoshitaka Iba
Yoshikazu Kurosawa
Kazuhiko Morino
Yoshinobu Okuno
Midori Shinohara
Kimiyasu Shiraki
Motohide Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical and Biological Laboratories Co Ltd
Original Assignee
Medical and Biological Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical and Biological Laboratories Co Ltd filed Critical Medical and Biological Laboratories Co Ltd
Publication of AU2001234125A1 publication Critical patent/AU2001234125A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2001234125A 2000-02-22 2001-02-22 Antibody library Abandoned AU2001234125A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-50543 2000-02-22
JP2000050543 2000-02-22
PCT/JP2001/001298 WO2001062907A1 (en) 2000-02-22 2001-02-22 Antibody library

Publications (1)

Publication Number Publication Date
AU2001234125A1 true AU2001234125A1 (en) 2001-09-03

Family

ID=18572310

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001234125A Abandoned AU2001234125A1 (en) 2000-02-22 2001-02-22 Antibody library

Country Status (5)

Country Link
US (1) US8101553B1 (en)
EP (1) EP1264885A4 (en)
JP (2) JP4656478B2 (en)
AU (1) AU2001234125A1 (en)
WO (1) WO2001062907A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR546801A0 (en) * 2001-06-05 2001-06-28 Commonwealth Scientific And Industrial Research Organisation Recombinant antibodies
AU2002313194B9 (en) * 2001-06-12 2008-06-05 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Human-type anti-blood coagulation factor VIII antibody
US7371849B2 (en) 2001-09-13 2008-05-13 Institute For Antibodies Co., Ltd. Methods of constructing camel antibody libraries
AR040778A1 (en) * 2002-08-06 2005-04-20 Glaxo Group Ltd ALTERED ANTIBODIES OR FUNCTIONAL FRAGMENTS THAT BIND MAG (GLICOPROTEIN ASSOCIATED WITH HONEY).
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
SE0301936D0 (en) * 2003-06-30 2003-06-30 Affibody Ab New polypeptide
EP1631315B1 (en) 2003-09-24 2014-07-30 Millennium Pharmaceuticals, Inc. Antibodies which bind human cxcr3
JPWO2005105998A1 (en) * 2004-04-27 2008-07-31 財団法人化学及血清療法研究所 Human anti-amyloid β peptide antibody and antibody fragment thereof
WO2006090750A1 (en) 2005-02-28 2006-08-31 Institute For Antibodies Co., Ltd. ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME
EP2004228A1 (en) * 2006-02-28 2008-12-24 Oncotherapy Science, Inc. Methods for damaging cells using effector functions of anti-epha4 antibodies
EP2078732B1 (en) 2006-07-10 2015-09-16 Fujita Health University Method of identifying a candidate diagnostic or therapeutic antibody using flow cytometry
KR100958308B1 (en) * 2007-10-15 2010-05-19 주식회사 아이지세라피 Antibody fragment expression vector and method for producing recombinant phage to display antibody using the vector
WO2009096162A1 (en) 2008-01-29 2009-08-06 Institute For Antibodies Co., Ltd. Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody
JPWO2009148150A1 (en) 2008-06-06 2011-11-04 国立大学法人富山大学 Influenza virus detection device
US8871207B2 (en) 2008-07-25 2014-10-28 Humabs, LLC Neutralizing anti-influenza A virus antibodies and uses thereof
MX2011000768A (en) * 2008-07-25 2011-10-05 Inst Research In Biomedicine NEUTRALIZING ANTIBODIES OF ANTI-INFLUENZA VIRUSES AND USES OF THE SAME.
KR100963507B1 (en) * 2009-11-30 2010-06-15 주식회사 아이지세라피 Antibody fragment expression vector and method for producing recombinant phage using the vector to display antibody
US9534042B2 (en) 2010-09-03 2017-01-03 Fujita Health University Influenza virus-neutralizing antibody and screening method therefor
EP2708560A4 (en) 2011-05-09 2015-01-14 Perseus Proteomics Inc ANTIBODIES SPECIFICALLY RECEIVING A TRANSFERRIN RECEPTOR
SI3418300T1 (en) 2011-07-18 2021-03-31 Institute For Research In Biomedicine Neutralizing antibodies against influenza A virus and their uses
CA2892992A1 (en) 2011-12-02 2013-06-06 Aimm Therapeutics B.V. Influenza a virus specific antibodies
US10112987B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide
US10112988B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide
US9273140B2 (en) 2012-05-10 2016-03-01 Fujita Health University Antibody for detecting DNA damage in cells utilizing cell membrane surface antigen Ly6D
SG11201505663YA (en) 2013-01-24 2015-08-28 Scripps Korea Antibody Inst Protein combination-based fv library, and preparation method therefor
KR20160068742A (en) 2013-09-04 2016-06-15 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 Dpp-4-targeting vaccine for treating diabetes
US10501737B2 (en) 2013-09-30 2019-12-10 Chugai Seiyaku Kabushiki Kaisha Method for producing antigen-binding molecule using modified helper phage
AU2014329609B2 (en) 2013-10-02 2019-09-12 Humabs Biomed Sa Neutralizing anti-influenza A antibodies and uses thereof
US11421025B2 (en) 2013-12-27 2022-08-23 Osaka University Treatment of IL-17A diseases
CA2947529C (en) 2014-05-02 2022-06-21 Shinshu University Antibody gene expression-secretion system
CN119161468A (en) 2014-07-15 2024-12-20 免疫医疗有限责任公司 Neutralizing anti-influenza B antibodies and uses thereof
BR112017025496A2 (en) 2015-06-01 2018-08-07 Medimmune, Llc ANTI-INFLUENCE NEUTRALIZING CONNECTION MOLECULES AND USES OF THE SAME
CN116271017A (en) 2016-01-13 2023-06-23 免疫医疗有限责任公司 The method of treating influenza A
WO2019138572A1 (en) * 2018-01-15 2019-07-18 オリンパス株式会社 Cell analysis device and cell analysis system
EP3767628B1 (en) * 2019-07-18 2024-03-27 Bayer Aktiengesellschaft Selection of antibodies / antibody fragments
KR20210095781A (en) 2020-01-24 2021-08-03 주식회사 에이프릴바이오 A multi-specific antibody comprising a fusion construct consisting of a Fab and a bioactive effector moiety

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005144A1 (en) 1988-11-11 1990-05-17 Medical Research Council Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
US6291159B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for producing polymers having a preselected activity
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
US6291158B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for tapping the immunological repertoire
EP0478627A4 (en) 1989-05-16 1992-08-19 William D. Huse Co-expression of heteromeric receptors
US6291160B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for producing polymers having a preselected activity
AU7247191A (en) 1990-01-11 1991-08-05 Molecular Affinities Corporation Production of antibodies using gene libraries
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US6476198B1 (en) * 1993-07-13 2002-11-05 The Scripps Research Institute Multispecific and multivalent antigen-binding polypeptide molecules
GB9722131D0 (en) * 1997-10-20 1997-12-17 Medical Res Council Method

Also Published As

Publication number Publication date
EP1264885A4 (en) 2007-02-21
JP5393639B2 (en) 2014-01-22
JP4656478B2 (en) 2011-03-23
WO2001062907A1 (en) 2001-08-30
JP2011087586A (en) 2011-05-06
EP1264885A1 (en) 2002-12-11
US8101553B1 (en) 2012-01-24

Similar Documents

Publication Publication Date Title
AU2001234125A1 (en) Antibody library
AU2001240819A1 (en) Proteomics database
AU2002210918A1 (en) Degraded agonist antibody
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AU2001283549A1 (en) Software-to-hardware compiler
AU4125001A (en) Computer case
AUPQ998100A0 (en) Application development
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2002365649A1 (en) Anti-dota antibody
IL136459A0 (en) Antibody library
AU2001220246A1 (en) Neckphone
AU2001239310A1 (en) Decahydro-isoquinolines
AU2002236477A1 (en) Fgf-affinity chromatography
AU2001258349A1 (en) Bisacylguanidine
AU2001290860A1 (en) Spas-1 cancer antigen
AU2001239773A1 (en) Baroplastic materials
AU2001237471A1 (en) Immunochemical methods
AU2001246934A1 (en) Agonist antibodies
AU2001220281A1 (en) Rollerboard for road-skiing
AU2001258924A1 (en) Microsatellite-aflp
AU2001294274A1 (en) Antibody inhibiting VPLF activity
AU7593800A (en) Small library works-in-a-drawer
AU2002221132A1 (en) Novel antibody
AU2001246864A1 (en) Hypotensors